LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹100 Cr | ₹89 Cr | ₹95 Cr | ₹87 Cr | ₹66 Cr |
What is the latest Operating Profit of LINCOLN PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹95 Cr |
| Mar2022 | ₹87 Cr |
| Mar2021 | ₹66 Cr |
How is Operating Profit of LINCOLN PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 12.00 | |
| Mar2024 | ₹89 Cr | -6.58 | |
| Mar2023 | ₹95 Cr | 9.52 | |
| Mar2022 | ₹87 Cr | 33.02 | |
| Mar2021 | ₹66 Cr | - | |
Compare Operating Profit of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,238.2 Cr | 1.3% | 6.7% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.3% |
6.7% |
9.1% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses